Longsworth Todd Christopher

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
18
Insider Sells Sum
$46.13M

Insider Activity of Longsworth Todd Christopher

The largest sale of all time was on 2019-09-03 and amounted to 311249 shares of NovoCure Limited for $27.34M.

Biography of Longsworth Todd Christopher

No biography is available at this moment.

2022-03-08SaleNovoCure Limited
NVCR
General Counsel
2,339
0.0023%
$70.10$163,964+11.28%
2022-03-03SaleNovoCure Limited
NVCR
General Counsel
1,094
0.0011%
$74.50$81,501+4.71%
2021-03-08SaleNovoCure Limited
NVCR
General Counsel
2,404
0.0024%
$130.81$314,458+1.98%
2021-03-04SaleNovoCure Limited
NVCR
General Counsel
3,084
0.0031%
$137.55$424,217-2.79%
2021-03-02SaleNovoCure Limited
NVCR
General Counsel
2,355
0.0023%
$152.05$358,085-14.45%
2021-01-15SaleNovoCure Limited
NVCR
General Counsel
63,814
0.064%
$172.48$11.01M-17.26%
2020-03-06SaleNovoCure Limited
NVCR
General Counsel
2,499
0.0025%
$69.53$173,765+18.67%
2020-02-28SaleNovoCure Limited
NVCR
General Counsel
2,643
0.0026%
$72.22$190,864+9.99%
2020-02-25SaleNovoCure Limited
NVCR
General Counsel
8,482
0.0086%
$81.16$688,365-0.07%
2019-09-03SaleNovoCure Limited
NVCR
General Counsel
311,249
0.3184%
$87.84$27.34M-13.73%
2019-02-28SaleNovoCure Limited
NVCR
General Counsel
4,736
0.005%
$53.68$254,228+41.16%
2019-02-25SaleNovoCure Limited
NVCR
General Counsel
18,650
0.0197%
$53.63$1M+40.93%
2019-01-25SaleNovoCure Limited
NVCR
General Counsel
23,748
0.0252%
$50.15$1.19M+42.64%
2019-01-24SaleNovoCure Limited
NVCR
General Counsel
30,000
0.0181%
$27.65$829,500+46.92%
2019-01-16SaleNovoCure Limited
NVCR
General Counsel
30,000
0.0183%
$26.15$784,500+53.04%
2019-01-09SaleNovoCure Limited
NVCR
General Counsel
30,000
0.0185%
$23.65$709,500+68.72%
2018-02-23SaleNovoCure Limited
NVCR
General Counsel
13,182
0.015%
$19.83$261,373+72.54%
2018-01-29SaleNovoCure Limited
NVCR
General Counsel
23,260
0.0168%
$15.36$357,274+35.59%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.